Please provide your email address to receive an email when new articles are posted on . “Elevated [IOP] is one of the major risk factors for development and progression of POAG [primary open-angle ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — The majority of patients who underwent laser trabeculoplasty or iStent implantation saw no ...

Multiple 5-, 6-, 7- and 8-Year Real-World Studies Published, Demonstrating Leading Efficacy & Safety Across the Entire Glaucoma Disease Spectrum SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos ...

San Clemente-based Glaukos Corp. anticipates strong revenue growth next year for its iStent products, based on a guarantee of reimbursement on procedures that use its iStent implant. Glaukos expects ...

CHERRY HILL, N.J. (WPVI) -- A new procedure is helping to preserve vision for some people with glaucoma. Glaucoma is a silent thief, affecting 3 million Americans, slowly robbing them of their sight.

(RTTNews) - Glaukos Corp. (GKOS) has submitted a supplemental pre-market approval application to the FDA for the iStent infinite Trabecular Micro-Bypass System. The iStent infinite is an ...

Matthew Traynor, MD, successfully completed iStent inject cases at Idaho Falls, Idaho-based Grand Teton Surgery Center, according to Glaukos Corp. Senior Regional Business Manager Jennifer Lee. Three ...

Glaukos Corporation GKOS recently submitted a supplemental pre-market approval (PMA) application to the FDA with respect to its iStent infinite Trabecular Micro-Bypass System. It is worth mentioning ...